Clinical Trials Browser

Phase 2 × Interventional × empagliflozin × Clear all

NCT06844669 2026-03-03

HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy

Phase 2 Active not recruiting

Breast Neoplasms, Heart Failure, Cardiotoxicity

NCT06818305 2025-12-11

EmFin-Nx

Phase 2 Terminated

Carcinoma, Renal Cell, Kidney Neoplasms, Renal Insufficiency, Chronic